Abbott Laboratories (ABT) Stock Price: $91.25+0.75 (+0.83%)
The total return cagr for Abbott Laboratories (ABT) stock is -30.21% over the past 12 months. The 3 year average growth rate is -1.58% and the 5 year cagr is -1.67%. Total return includes dividends reinvested.
The closing share price for Abbott Laboratories (ABT) stock was $91.25 for Tuesday, June 9, 2026, up +0.83% from the previous day.
ABT Price Chart
ABT Key Metrics
See All MetricsABT Earnings Preview
Next Earnings Date
Jul 16, 2026
37 days away
EPS Estimate
1.28
Revenue Est.
$12.54B
Last Quarter Results
EPS
$1.15
vs Estimate
$1.15
Revenue
$11.16B
vs Estimate
$11.00B
ABT Analyst Ratings
Consensus Rating
Based on 24 analysts
Average Price Target
$117.29
+28.5% upside
Low
$92.00
Current
$91.25
High
$135.00
ABT Analyst Estimates
Earnings Per Share (EPS) Estimates
Quarterly
| Period | Low | Avg | High | # Analysts |
|---|---|---|---|---|
| Q1 2027 | N/A | $1.29 | N/A | 10 |
| Q2 2027 | N/A | $1.44 | N/A | 6 |
| Q3 2027 | N/A | $1.58 | N/A | 7 |
| Q4 2027 | N/A | $1.74 | N/A | 6 |
Annual
| Period | Low | Avg | High | # Analysts |
|---|---|---|---|---|
| FY 2027 | N/A | $6.05 | N/A | 15 |
| FY 2028 | N/A | $6.75 | N/A | 9 |
Revenue Estimates
Quarterly
| Period | Low | Avg | High | # Analysts |
|---|---|---|---|---|
| Q1 2027 | N/A | $12.78B | N/A | 10 |
| Q2 2027 | N/A | $13.50B | N/A | 6 |
| Q3 2027 | N/A | $14.11B | N/A | 7 |
| Q4 2027 | N/A | $14.54B | N/A | 6 |
Annual
| Period | Low | Avg | High | # Analysts |
|---|---|---|---|---|
| FY 2027 | N/A | $54.94B | N/A | 15 |
| FY 2028 | N/A | $58.93B | N/A | 9 |
Source: FMP Analyst Consensus Estimates. Forward P/E calculated using average EPS estimate for the nearest fiscal year.
ABT Competitors' Key Metrics
| Stock | Market Cap | Close Price | Price Change | TTM Total Return | 5Y CAGR | 10Y CAGR |
|---|---|---|---|---|---|---|
| 1ABT | $158.94B | $91.25 | +0.83% | -30.21% | -1.67% | +10.97% |
ABT Charts
Valuation Charts
Performance Charts
CAGR Charts
Financial Statement Charts
- Revenue
- Gross Profit
- Operating Income
- Net Income
- EBITDA
- Free Cash Flow
- Operating Cash Flow
- Capital Expenditure
- Acquisitions
- Share Buybacks
- Stock-Based Compensation
- Total Assets
- Total Equity
- Cash & Equivalents
- Accounts Receivable
- Inventory
- PP&E
- Goodwill
- Accounts Payable
- Retained Earnings
- Total Debt
- Long-Term Debt
- Short-Term Debt